| Ovidrel (choriogonadotropin alfa) / EMD Serono |
NCT01205009: Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor Responders |
|
|
| Unknown status | N/A | 100 | RoW | Ovitrelle | Hadassah Medical Organization | Infertility | 03/12 | | | |
NCT02813239: Dual Triggering in Patients With a High Immature Oocyte Rate |
|
|
| Completed | N/A | 81 | Europe | hCG, OVITRELLE (Merck Serono), hCG + GnRH agonist, Ovitrelle (Merck Serono) + Decapeptyl (Ipsen Pharma) | IVI Madrid | INFERTILITY | 11/14 | 11/15 | | |
GnRH, NCT02635607: Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol |
|
|
| Unknown status | N/A | 200 | NA | Follitropin Beta, Puregon, Ganirelix, Orgalutran, rhCG, Ovidrel, triptorelin, Decapeptyl | Chong Qing Reproducive and Genetic Institute, Merck Sharp & Dohme LLC | Infertility | 12/16 | 03/17 | | |
NCT02368964: IVF Treatment in Women With Immature Oocytes in Previous Cycle |
|
|
| Completed | N/A | 100 | RoW | GnRH agonist 0.2 mg + hCG 250 mcg, GnRH agonist - Decapeptyl , hCG - Ovitrelle, high dose hCG 500 mcg, Ovitrelle | Sheba Medical Center | Infertility | 06/20 | 06/20 | | |
NCT03300518: Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient |
|
|
| Completed | N/A | 552 | RoW | Follitropin Beta;MSD, Puregon, Ganirelix, Orgalutran, hCG, Ovidrel, estradiol valerate, progynova | Reproductive & Genetic Hospital of CITIC-Xiangya, Merck Sharp & Dohme LLC | Infertility | 06/21 | 08/21 | | |
NCT05076981: Progesterone Levels During Ovulation and Luteal Phase |
|
|
| Completed | N/A | 6 | RoW | human chorionic gonadotropin, Ovitrelle | ART Fertility Clinics LLC | Infertility, Female | 12/21 | 12/21 | | |
NCT05969834: HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome |
|
|
| Completed | N/A | 100 | RoW | uHCG, Choriomon, rHCG, Ovitrelle, uHCG and GnRHa, Decapeptyl and Choriomon | Mansoura University | Infertility | 07/22 | 08/22 | | |
